Cervical cancer kills over 75,000 women every year in India alone, despite being one of the most preventable cancers if detected early. The challenge is that Pap smear and colposcopy—the gold standard screening methods—are slow, error-prone, and heavily dependent on scarce specialists, leaving millions of women in underserved regions without timely diagnosis.

Manalife AI is changing this. We digitize and automate the entire cervical cancer screening workflow—from slide preparation and staining to digital scanning and AI-powered image analysis—cutting diagnosis time from weeks to just 20 minutes. Our AI models classify images based on the Bethesda system, generate instant reports, and seamlessly integrate with mobile colposcopy, making large-scale, affordable screening possible.

With government-validated technology transfers and in-house AI innovation, Manalife AI is poised to bring high-quality cervical cancer screening to every woman, everywhere—especially in low- and middle-income countries where it’s needed most.